172 related articles for article (PubMed ID: 22826418)
1. PET/CT and renal pathology: a blind spot for radiologists? Part 2--lymphoma, leukemia, and metastatic disease.
Zukotynski K; Lewis A; O'Regan K; Jacene H; Sakellis C; Almodovar S; Israel D
AJR Am J Roentgenol; 2012 Aug; 199(2):W168-74. PubMed ID: 22826418
[TBL] [Abstract][Full Text] [Related]
2. PET/CT and renal pathology: a blind spot for radiologists? Part 1, primary pathology.
Zukotynski K; Lewis A; O'Regan K; Jacene H; Sakellis C; Krajewski K; Israel D
AJR Am J Roentgenol; 2012 Aug; 199(2):W163-7. PubMed ID: 22826417
[TBL] [Abstract][Full Text] [Related]
3. FDG PET in solitary metastastic/secondary tumor of the kidney: a report of three cases and a review of the relevant literature.
Kaneta T; Hakamatsuka T; Yamada T; Takase K; Sato A; Higano S; Kinomura S; Fukuda H; Takahashi S; Yamada S
Ann Nucl Med; 2006 Jan; 20(1):79-82. PubMed ID: 16485580
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG-PET/CT in potentially advanced renal cell carcinoma: a role in treatment decisions and prognosis estimation.
Ferda J; Ferdova E; Hora M; Hes O; Finek J; Topolcan O; Kreuzberg B
Anticancer Res; 2013 Jun; 33(6):2665-72. PubMed ID: 23749925
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.
Zhou WL; Wu HB; Weng CS; Han YJ; Wang M; Huang S; Wang QS
Nucl Med Commun; 2014 Nov; 35(11):1107-11. PubMed ID: 25144562
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT evaluation of lymphoma with renal involvement: comparison with renal carcinoma.
Ye XH; Chen LH; Wu HB; Feng J; Zhou WL; Yang RM; Bu ZB; Ding Y; Guan J; Wang QS
South Med J; 2010 Jul; 103(7):642-9. PubMed ID: 20531045
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the diagnostic performance of (18)F-FDG-PET/CT for detection and characterization of solid renal malignancies.
Nakhoda Z; Torigian DA; Saboury B; Hofheinz F; Alavi A
Hell J Nucl Med; 2013; 16(1):19-24. PubMed ID: 23529389
[TBL] [Abstract][Full Text] [Related]
8. (18)F-FDG PET/CT in primary right eyelid lymphoma.
Wang WH; Zhan FH; Li YJ; Dang CJ
Clin Nucl Med; 2013 Apr; 38(4):280-2. PubMed ID: 23455533
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
11. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
[TBL] [Abstract][Full Text] [Related]
12. PET/CT: appropriate application in lymphoma.
Wang X
Chin Clin Oncol; 2015 Mar; 4(1):4. PubMed ID: 25841711
[TBL] [Abstract][Full Text] [Related]
13. F-18 FDG PET/CT findings of aggressive NK-cell leukemia.
Derlin T; Mester J; Klutmann S
Clin Nucl Med; 2011 Oct; 36(10):932-3. PubMed ID: 21892052
[No Abstract] [Full Text] [Related]
14. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Basu S; Li G; Bural G; Alavi A
Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
[TBL] [Abstract][Full Text] [Related]
15. Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma.
Tirumani SH; LaCasce AS; Jacene HA
PET Clin; 2015 Apr; 10(2):207-25. PubMed ID: 25829087
[TBL] [Abstract][Full Text] [Related]
16. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
18. Breast carcinoma metastatic to renal oncocytoma detected on F-18-FDG PET/CT.
Fox JJ; Rohan S; Pandit-Taskar N
Clin Nucl Med; 2009 May; 34(5):294-5. PubMed ID: 19387207
[No Abstract] [Full Text] [Related]
19. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
Chiewvit S; Thephamongkhol K; Ubolnuch K; Pooliam J; Phongsawat N; Chiewvit P
J Med Assoc Thai; 2014 Jan; 97(1):85-94. PubMed ID: 24701734
[TBL] [Abstract][Full Text] [Related]
20. PET/computed tomography and lymphoma.
Allen-Auerbach M; de Vos S; Czernin J
Radiol Clin North Am; 2013 Sep; 51(5):833-44. PubMed ID: 24010908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
